Dr. Gottlieb says J&J Covid vaccine trial yields very good result and vaccine will aid U.S. pandemic response

Former FDA chief Dr. Scott Gottlieb said Johnson & Johnson's single-dose Covid vaccine will be a "great addition" to the U.S. pandemic response.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.